Circulation
Journal
Overview
publication venue for
-
American College of Cardiology/American Heart Association clinical competence statement on echocardiography: a report of the American College of Cardiology/American Heart Association/American College of Physicians--American Society of Internal Medicine Task Force on Clinical Competence.
2003
-
Acute profound thrombocytopenia after C7E3 Fab (abciximab) therapy.
1997
-
Images in Cardiovascular medicine. Noninvasive diagnosis of cor triatriatum.
1995
-
ABCG2-Expressing Clonal Repopulating Endothelial Cells Serve to Form and Maintain Blood Vessels.
2024
-
Positive Vasoreactivity Testing in Pulmonary Arterial Hypertension: Therapeutic Consequences, Treatment Patterns, and Outcomes in the Modern Management Era.
2024
-
Comparative Discrimination of Life's Simple 7 and Life's Essential 8 to Stratify Cardiovascular Risk: Is the Added Complexity Worth It?
2023
-
Relating Lipoprotein(a) Concentrations to Cardiovascular Event Risk After Acute Coronary Syndrome: A Comparison of Three Tests.
2023
-
Fractional Flow Reserve-Guided PCI or Coronary Bypass Surgery for 3-Vessel Coronary Artery Disease: 3-Year Follow-Up of the FAME 3 Trial..
148.
2023
-
Graft Failure After Coronary Artery Bypass Grafting and Its Association With Patient Characteristics and Clinical Events: A Pooled Individual Patient Data Analysis of Clinical Trials With Imaging Follow-Up.
2023
-
ROMA-Women: Innovative Approaches for the First Cardiac Surgery Trial in Women.
2023
-
Survival After Invasive or Conservative Management of Stable Coronary Disease..
147.
2022
-
Substrate Ablation by Multivein, Multiballoon Coronary Venous Ethanol for Refractory Ventricular Tachycardia in Structural Heart Disease..
146.
2022
-
Apolipoprotein B, Residual Cardiovascular Risk After Acute Coronary Syndrome, and Effects of Alirocumab..
146.
2022
-
The Use of Intraoperative Transit Time Flow Measurement for Coronary Artery Bypass Surgery: Systematic Review of the Evidence and Expert Opinion Statements..
144.
2021
-
The Need to Expand the Framework of Environmental Determinants of Cardiovascular Health From Climate Change to Planetary Health: Trial by Wildfire..
143.
2021
-
Extracellular Vesicles From Epicardial Fat Facilitate Atrial Fibrillation..
143.
2021
-
COVID-19 at 1 Year: American Heart Association Presidents Reflect on the Pandemic..
143.
2021
-
Number of Social Determinants of Health and Fatal and Nonfatal Incident Coronary Heart Disease in the REGARDS Study..
143.
2020
-
Myocardial Injury in Adults Hospitalized With COVID-19..
142.
2020
-
Epigenetic Reader BRD4 (Bromodomain-Containing Protein 4) Governs Nucleus-Encoded Mitochondrial Transcriptome to Regulate Cardiac Function..
142.
2020
-
Forty-Year Shifting Distribution of Systolic Blood Pressure With Population Hypertension Treatment and Control..
142.
2020
-
Long-Term Results of the RAPCO Trials..
142.
2020
-
Postoperative Atrial Fibrillation and Long-Term Risk of Stroke After Isolated Coronary Artery Bypass Graft Surgery..
142.
2020
-
Reservoir of Fibroblasts Promotes Recovery From Limb Ischemia..
142.
2020
-
Impact of Transcatheter Aortic Valve Durability on Life Expectancy in Low-Risk Patients With Severe Aortic Stenosis..
142.
2020
-
Guidance for Cardiac Electrophysiology During the COVID-19 Pandemic from the Heart Rhythm Society COVID-19 Task Force; Electrophysiology Section of the American College of Cardiology; and the Electrocardiography and Arrhythmias Committee of the Council on Clinical Cardiology, American Heart Association..
141.
2020
-
Inducible Pluripotent Stem Cell-Derived Cardiomyocytes Reveal Aberrant Extracellular Regulated Kinase 5 and Mitogen-Activated Protein Kinase Kinase 1/2 Signaling Concomitantly Promote Hypertrophic Cardiomyopathy in RAF1-Associated Noonan Syndrome..
140.
2020
-
Effects of Exercise Therapy Dosing Schedule on Impaired Cardiorespiratory Fitness in Patients With Primary Breast Cancer: A Randomized Controlled Trial..
141.
2020
-
Call to Action: Rural Health: A Presidential Advisory From the American Heart Association and American Stroke Association..
141.
2020
-
Advancing Healthcare Reform: The American Heart Association's 2020 Statement of Principles for Adequate, Accessible, and Affordable Health Care: A Presidential Advisory From the American Heart Association..
141.
2020
-
Risk Categorization Using New American College of Cardiology/American Heart Association Guidelines for Cholesterol Management and Its Relation to Alirocumab Treatment Following Acute Coronary Syndromes..
140.
2019
-
Nuclear S-Nitrosylation Defines an Optimal Zone for Inducing Pluripotency..
140.
2019
-
Microvascular Disease, Peripheral Artery Disease, and Amputation..
140.
2019
-
Polycystin-1 Assembles With Kv Channels to Govern Cardiomyocyte Repolarization and Contractility..
140.
2019
-
Impact of Bridge to Transplantation With Continuous-Flow Left Ventricular Assist Devices on Posttransplantation Mortality..
140.
2019
-
Effect of Alirocumab on Mortality After Acute Coronary Syndromes..
140.
2019
-
Fibroblast Primary Cilia Are Required for Cardiac Fibrosis..
139.
2019
-
Glycolytic Switch Is Required for Transdifferentiation to Endothelial Lineage..
139.
2019
-
Potential Cardiovascular Disease Events Prevented with Adoption of the 2017 American College of Cardiology/American Heart Association Blood Pressure Guideline..
139.
2019
-
Multiple Arterial Grafting Is Associated With Better Outcomes for Coronary Artery Bypass Grafting Patients..
138.
2018
-
Fractional Flow Reserve and Quality-of-Life Improvement After Percutaneous Coronary Intervention in Patients With Stable Coronary Artery Disease..
138.
2018
-
Planning and Conducting the ISCHEMIA Trial..
138.
2018
-
TBX20 Regulates Angiogenesis Through the Prokineticin 2-Prokineticin Receptor 1 Pathway..
138.
2018
-
B-Type Natriuretic Peptide Assessment in Patients Undergoing Revascularization for Left Main Coronary Artery Disease: Analysis From the EXCEL Trial..
138.
2018
-
Rediscovering the Orbit of Percutaneous Coronary Intervention After ORBITA..
137.
2018
-
Association of Human Immunodeficiency Virus Infection and Risk of Peripheral Artery Disease..
138.
2018
-
PCSK9 Variants, Low-Density Lipoprotein Cholesterol, and Neurocognitive Impairment: Reasons for Geographic and Racial Differences in Stroke Study (REGARDS)..
137.
2017
-
Pioglitazone Prevents Stroke in Patients With a Recent Transient Ischemic Attack or Ischemic Stroke: A Planned Secondary Analysis of the IRIS Trial (Insulin Resistance Intervention After Stroke)..
137.
2017
-
Randomized Comparison of Ridaforolimus- and Zotarolimus-Eluting Coronary Stents in Patients With Coronary Artery Disease: Primary Results From the BIONICS Trial (BioNIR Ridaforolimus-Eluting Coronary Stent System in Coronary Stenosis)..
136.
2017
-
Black-White Differences in Incident Fatal, Nonfatal, and Total Coronary Heart Disease..
136.
2017
-
Incident Cardiovascular Disease Among Adults With Blood Pressure <140/90 mm Hg..
136.
2017
-
Associations Between Adding a Radial Artery Graft to Single and Bilateral Internal Thoracic Artery Grafts and Outcomes: Insights From the Arterial Revascularization Trial..
136.
2017
-
Prospective Study of Adenosine on Atrioventricular Nodal Conduction in Pediatric and Young Adult Patients After Heart Transplantation..
135.
2017
-
Prognostic Value of Noninvasive Cardiovascular Testing in Patients With Stable Chest Pain: Insights From the PROMISE Trial (Prospective Multicenter Imaging Study for Evaluation of Chest Pain)..
135.
2017
-
Impact of Practice-Based Management of Pulmonary Artery Pressures in 2000 Patients Implanted With the CardioMEMS Sensor..
135.
2017
-
Safety and Tolerability of CSL112, a Reconstituted, Infusible, Plasma-Derived Apolipoprotein A-I, After Acute Myocardial Infarction: The AEGIS-I Trial (ApoA-I Event Reducing in Ischemic Syndromes I)..
134.
2016
-
Extended-Duration Betrixaban Reduces the Risk of Stroke Versus Standard-Dose Enoxaparin Among Hospitalized Medically Ill Patients: An APEX Trial Substudy (Acute Medically Ill Venous Thromboembolism Prevention With Extended Duration Betrixaban)..
135.
2016
-
Citizen Petition to the US Food and Drug Administration to Change Prescribing Guidelines: The Metformin Experience..
134.
2016
-
Pregnancy and the Risk of Aortic Dissection or Rupture: A Cohort-Crossover Analysis..
134.
2016
-
Treatment of Higher-Risk Patients With an Indication for Revascularization: Evolution Within the Field of Contemporary Percutaneous Coronary Intervention..
134.
2016
-
Consistent Reduction in Periprocedural Myocardial Infarction With Cangrelor as Assessed by Multiple Definitions: Findings From CHAMPION PHOENIX (Cangrelor Versus Standard Therapy to Achieve Optimal Management of Platelet Inhibition)..
134.
2016
-
The Heart of 25 by 25: Achieving the Goal of Reducing Global and Regional Premature Deaths From Cardiovascular Diseases and Stroke: A Modeling Study From the American Heart Association and World Heart Federation..
133.
2016
-
Invasive Assessment of Coronary Physiology Predicts Late Mortality After Heart Transplantation..
133.
2016
-
Efficacy and Safety of Cangrelor in Women Versus Men During Percutaneous Coronary Intervention: Insights From the Cangrelor versus Standard Therapy to Achieve Optimal Management of Platelet Inhibition (CHAMPION PHOENIX) Trial..
133.
2016
-
Association of Serum Lipids and Coronary Heart Disease in Contemporary Observational Studies..
133.
2015
-
Frequency and Predictors of Internal Mammary Artery Graft Failure and Subsequent Clinical Outcomes: Insights From the Project of Ex-vivo Vein Graft Engineering via Transfection (PREVENT) IV Trial..
133.
2015
-
Critical Roles of STAT3 in β-Adrenergic Functions in the Heart..
133.
2015
-
Cardiology Patient Page. ABCDE Steps for Heart and Vascular Wellness Following a Prostate Cancer Diagnosis..
132.
2015
-
Depression and human immunodeficiency virus infection are risk factors for incident heart failure among veterans: Veterans Aging Cohort Study..
132.
2015
-
Southern Dietary Pattern is Associated With Hazard of Acute Coronary Heart Disease in the Reasons for Geographic and Racial Differences in Stroke (REGARDS) Study..
132.
2015
-
Fibroblast growth factor 21 prevents atherosclerosis by suppression of hepatic sterol regulatory element-binding protein-2 and induction of adiponectin in mice..
131.
2015
-
Oxidative stress activates endothelial innate immunity via sterol regulatory element binding protein 2 (SREBP2) transactivation of microRNA-92a..
131.
2014
-
Transdifferentiation of human fibroblasts to endothelial cells: role of innate immunity..
131.
2014
-
Relation of antiphospholipid antibodies to postmortem brain infarcts in older people..
131.
2014
-
CD82 restrains pathological angiogenesis by altering lipid raft clustering and CD44 trafficking in endothelial cells..
130.
2014
-
Cost-effectiveness of follow-up of pulmonary nodules incidentally detected on cardiac computed tomographic angiography in patients with suspected coronary artery disease..
130.
2014
-
Mesenchymal precursor cells as adjunctive therapy in recipients of contemporary left ventricular assist devices..
129.
2014
-
Fibromuscular dysplasia: state of the science and critical unanswered questions: a scientific statement from the American Heart Association..
129.
2014
-
Racial and regional differences in venous thromboembolism in the United States in 3 cohorts..
129.
2014
-
Ryanodine receptor-mediated calcium leak drives progressive development of an atrial fibrillation substrate in a transgenic mouse model..
129.
2014
-
Growth properties of cardiac stem cells are a novel biomarker of patients' outcome after coronary bypass surgery..
129.
2013
-
Biomarkers in relation to the effects of ticagrelor in comparison with clopidogrel in non-ST-elevation acute coronary syndrome patients managed with or without in-hospital revascularization: a substudy from the Prospective Randomized Platelet Inhibition and Patient Outcomes (PLATO) trial..
129.
2013
-
Vascular progenitors from cord blood-derived induced pluripotent stem cells possess augmented capacity for regenerating ischemic retinal vasculature..
129.
2013
-
Alloantibody and complement promote T cell-mediated cardiac allograft vasculopathy through noncanonical nuclear factor-κB signaling in endothelial cells..
128.
2013
-
Comparison of transendocardial and intracoronary CD34+ cell transplantation in patients with nonischemic dilated cardiomyopathy..
128.
2013
-
Primary arterial switch operation as a strategy for total correction of Taussig-Bing anomaly: a 21-year experience..
128.
2013
-
Stent thrombosis with ticagrelor versus clopidogrel in patients with acute coronary syndromes: an analysis from the prospective, randomized PLATO trial..
128.
2013
-
Unexpected effect of proton pump inhibitors: elevation of the cardiovascular risk factor asymmetric dimethylarginine..
128.
2013
-
Adoption of radial access and comparison of outcomes to femoral access in percutaneous coronary intervention: an updated report from the national cardiovascular data registry (2007-2012)..
127.
2013
-
Sex differences in the effectiveness of early coronary computed tomographic angiography compared with standard emergency department evaluation for acute chest pain: the rule-out myocardial infarction with Computer-Assisted Tomography (ROMICAT)-II Trial..
127.
2013
-
Management of patients with atrial fibrillation (compilation of 2006 ACCF/AHA/ESC and 2011 ACCF/AHA/HRS recommendations): a report of the American College of Cardiology/American Heart Association Task Force on practice guidelines..
127.
2013
-
Pulmonary hyperinflation and left ventricular mass: the Multi-Ethnic Study of Atherosclerosis COPD Study..
127.
2013
-
Genome- and phenome-wide analyses of cardiac conduction identifies markers of arrhythmia risk..
127.
2013
-
2013 ACCF/AHA key data elements and definitions for measuring the clinical management and outcomes of patients with acute coronary syndromes and coronary artery disease: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Clinical Data Standards (Writing Committee to Develop Acute Coronary Syndromes and Coronary Artery Disease Clinical Data Standards)..
127.
2013
-
Prospective, multicenter study of ventricular assist device infections..
127.
2013
-
Conversion of cardiovascular conference abstracts to publications..
126.
2012
-
Short- and long-term outcomes of coronary stenting in women versus men: results from the National Cardiovascular Data Registry Centers for Medicare & Medicaid services cohort..
126.
2012
-
Coronary artery bypass grafting using the radial artery: clinical outcomes, patency, and need for reintervention..
126.
2012
-
A prospective, randomized clinical trial of hemodynamic support with Impella 2.5 versus intra-aortic balloon pump in patients undergoing high-risk percutaneous coronary intervention: the PROTECT II study..
126.
2012
-
Cyclooxygenase-2-derived prostacyclin regulates arterial thrombus formation by suppressing tissue factor in a sirtuin-1-dependent-manner..
126.
2012
-
Association between major perioperative hemorrhage and stroke or Q-wave myocardial infarction..
126.
2012
-
Sustained ventricular tachycardia and ventricular fibrillation complicating non-ST-segment-elevation acute coronary syndromes..
126.
2012
-
β-adrenergic receptor stimulation transactivates protease-activated receptor 1 via matrix metalloproteinase 13 in cardiac cells..
125.
2012
-
Ventricular assist device implantation corrects myocardial lipotoxicity, reverses insulin resistance, and normalizes cardiac metabolism in patients with advanced heart failure..
125.
2012
-
Association of proton pump inhibitor use on cardiovascular outcomes with clopidogrel and ticagrelor: insights from the platelet inhibition and patient outcomes trial..
125.
2012
-
In Memoriam of John T. Shepherd, MD, DSc..
125.
2012
-
Relationship between vein graft failure and subsequent clinical outcomes after coronary artery bypass surgery..
125.
2012
-
ST-elevation acute coronary syndromes in the Platelet Inhibition and Patient Outcomes (PLATO) trial: insights from the ECG substudy..
125.
2011
-
An unsuspected property of natriuretic peptides: promotion of calcium-dependent catecholamine release via protein kinase G-mediated phosphodiesterase type 3 inhibition..
125.
2011
-
Clinical implications of electrocardiographic left ventricular strain and hypertrophy in asymptomatic patients with aortic stenosis: the Simvastatin and Ezetimibe in Aortic Stenosis study..
125.
2011
-
Randomized trial of cutting balloon compared with high-pressure angioplasty for the treatment of resistant pulmonary artery stenosis..
124.
2011
-
Anticoagulation with the oral direct thrombin inhibitor dabigatran does not enlarge hematoma volume in experimental intracerebral hemorrhage..
124.
2011
-
Clinical and economic outcomes of liberal versus selective drug-eluting stent use: insights from temporal analysis of the multicenter Evaluation of Drug Eluting Stents and Ischemic Events (EVENT) registry..
124.
2011
-
Saphenous vein grafts with multiple versus single distal targets in patients undergoing coronary artery bypass surgery: one-year graft failure and five-year outcomes from the Project of Ex-Vivo Vein Graft Engineering via Transfection (PREVENT) IV trial..
124.
2011
-
Ticagrelor compared with clopidogrel by geographic region in the Platelet Inhibition and Patient Outcomes (PLATO) trial..
124.
2011
-
Calcineurin splicing variant calcineurin Aβ1 improves cardiac function after myocardial infarction without inducing hypertrophy..
123.
2011
-
Randomized clinical trial of aspirin and simvastatin for pulmonary arterial hypertension: ASA-STAT..
123.
2011
-
Identification and classification of acute cardiac rejection by intragraft transcriptional profiling..
123.
2011
-
ACCF/AHA 2011 expert consensus document on hypertension in the elderly: a report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents..
123.
2011
-
Reversal of hyperlipidemia with a genetic switch favorably affects the content and inflammatory state of macrophages in atherosclerotic plaques..
123.
2011
-
Upstream clopidogrel use and the efficacy and safety of early eptifibatide treatment in patients with acute coronary syndrome: an analysis from the Early Glycoprotein IIb/IIIa Inhibition in Patients with Non-ST-Segment Elevation Acute Coronary Syndrome (EARLY ACS) trial..
123.
2011
-
Humanized mouse model of thrombosis is predictive of the clinical efficacy of antiplatelet agents..
123.
2011
-
2011 ACCF/AHA/HRS focused update on the management of patients with atrial fibrillation (updating the 2006 guideline): a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines..
123.
2010
-
Heart disease and stroke statistics--2011 update: a report from the American Heart Association..
123.
2010
-
Ticagrelor versus clopidogrel in patients with ST-elevation acute coronary syndromes intended for reperfusion with primary percutaneous coronary intervention: A Platelet Inhibition and Patient Outcomes (PLATO) trial subgroup analysis..
122.
2010
-
Magnetic resonance imaging of carotid atherosclerotic plaque in clinically suspected acute transient ischemic attack and acute ischemic stroke..
122.
2010
-
Post-heart transplant survival is inferior at low-volume centers across all risk strata..
122.
2010
-
Ticagrelor versus clopidogrel in acute coronary syndromes in relation to renal function: results from the Platelet Inhibition and Patient Outcomes (PLATO) trial..
122.
2010
-
Aldehyde dehydrogenase activation prevents reperfusion arrhythmias by inhibiting local renin release from cardiac mast cells..
122.
2010
-
First clinical application of an actively reversible direct factor IXa inhibitor as an anticoagulation strategy in patients undergoing percutaneous coronary intervention..
122.
2010
-
There is a role for industry-sponsored education in cardiology..
121.
2010
-
Evaluation of a new heparin agent in percutaneous coronary intervention: results of the phase 2 evaluation of M118 IN pErcutaNeous Coronary intErvention (EMINENCE) Trial..
121.
2010
-
High-sensitivity troponin T concentrations in acute chest pain patients evaluated with cardiac computed tomography..
121.
2010
-
Nitrite potently inhibits hypoxic and inflammatory pulmonary arterial hypertension and smooth muscle proliferation via xanthine oxidoreductase-dependent nitric oxide generation..
121.
2009
-
Hyperhomocysteinemia promotes inflammatory monocyte generation and accelerates atherosclerosis in transgenic cystathionine beta-synthase-deficient mice..
120.
2009
-
Careers for clinician investigators..
119.
2009
-
Apixaban, an oral, direct, selective factor Xa inhibitor, in combination with antiplatelet therapy after acute coronary syndrome: results of the Apixaban for Prevention of Acute Ischemic and Safety Events (APPRAISE) trial..
119.
2009
-
Incidence and prognostic significance of thrombocytopenia developed during acute coronary syndrome in contemporary clinical practice..
119.
2009
-
Prognostic value of changes in the electrocardiographic strain pattern during antihypertensive treatment: the Losartan Intervention for End-Point Reduction in Hypertension Study (LIFE)..
119.
2009
-
Local inflammation and hypoxia abolish the protective anticontractile properties of perivascular fat in obese patients..
119.
2009
-
Reciprocal regulation of myocardial microRNAs and messenger RNA in human cardiomyopathy and reversal of the microRNA signature by biomechanical support..
119.
2009
-
Weekend versus weekday admission and mortality after acute pulmonary embolism..
119.
2009
-
Prevalence, prognosis, and implications of isolated minor nonspecific ST-segment and T-wave abnormalities in older adults: Cardiovascular Health Study..
118.
2008
-
Predictive value of myocardial perfusion single-photon emission computed tomography and the impact of renal function on cardiac death..
118.
2008
-
Electrophysiological consequences of acute regional ischemia/reperfusion in neonatal rat ventricular myocyte monolayers..
118.
2008
-
Incidence and risk factors for stroke in American Indians: the Strong Heart Study..
118.
2008
-
Dynamic mechanism for initiation of ventricular fibrillation in vivo..
118.
2008
-
Prevalence and prognostic significance of preprocedural cardiac troponin elevation among patients with stable coronary artery disease undergoing percutaneous coronary intervention: results from the evaluation of drug eluting stents and ischemic events registry..
118.
2008
-
Acute pharmacological conversion of atrial fibrillation to sinus rhythm: is short-term symptomatic therapy worth it? A report from the December 2007 Meeting of the Cardiovascular and Renal Drugs Advisory Committee of the Food and Drug Administration..
117.
2008
-
Phase 1b randomized study of antidote-controlled modulation of factor IXa activity in patients with stable coronary artery disease..
117.
2008
-
Left ventricular morphology and systolic function in sleep-disordered breathing: the Sleep Heart Health Study..
117.
2008
-
Cardiac autonomic dysfunction: effects from particulate air pollution and protection by dietary methyl nutrients and metabolic polymorphisms..
117.
2008
-
Effect of rosuvastatin therapy on coronary artery stenoses assessed by quantitative coronary angiography: a study to evaluate the effect of rosuvastatin on intravascular ultrasound-derived coronary atheroma burden..
117.
2008
-
Intracoronary KAI-9803 as an adjunct to primary percutaneous coronary intervention for acute ST-segment elevation myocardial infarction..
117.
2008
-
Utility of cardiac monitoring in fetuses at risk for congenital heart block: the PR Interval and Dexamethasone Evaluation (PRIDE) prospective study..
117.
2008
-
Noninvasive in vivo imaging of monocyte trafficking to atherosclerotic lesions..
117.
2008
-
Initial aspirin dose and outcome among ST-elevation myocardial infarction patients treated with fibrinolytic therapy..
117.
2007
-
Time to coronary angiography and outcomes among patients with high-risk non ST-segment elevation acute coronary syndromes: results from the SYNERGY trial..
116.
2007
-
Left ventricular untwisting rate by speckle tracking echocardiography..
116.
2007
-
Differentiation, survival, and function of embryonic stem cell derived endothelial cells for ischemic heart disease..
116.
2007
-
Beta2-microglobulin as a biomarker in peripheral arterial disease: proteomic profiling and clinical studies..
116.
2007
-
Tyrosine hydroxylase, the rate-limiting enzyme in catecholamine biosynthesis: discovery of common human genetic variants governing transcription, autonomic activity, and blood pressure in vivo..
116.
2007
-
Regression of electrocardiographic left ventricular hypertrophy during antihypertensive therapy and reduction in sudden cardiac death: the LIFE Study..
116.
2007
-
Outcomes of left ventricular assist device implantation as destination therapy in the post-REMATCH era: implications for patient selection..
116.
2007
-
Systemic lupus erythematosus predicts increased left ventricular mass..
116.
2007
-
L-arginine supplementation in peripheral arterial disease: no benefit and possible harm..
116.
2007
-
Prevalence and prognostic significance of wall-motion abnormalities in adults without clinically recognized cardiovascular disease: the Strong Heart Study..
116.
2007
-
Cardiac improvement during mechanical circulatory support: a prospective multicenter study of the LVAD Working Group..
115.
2007
-
Mechanism underlying initiation of paroxysmal atrial flutter/atrial fibrillation by ectopic foci: a simulation study..
115.
2007
-
Global diastolic strain rate for the assessment of left ventricular relaxation and filling pressures..
115.
2007
-
Cardiac and systemic hemodynamic characteristics of hypertension and prehypertension in adolescents and young adults: the Strong Heart Study..
115.
2007
-
First-in-human experience of an antidote-controlled anticoagulant using RNA aptamer technology: a phase 1a pharmacodynamic evaluation of a drug-antidote pair for the controlled regulation of factor IXa activity..
114.
2006
-
Survival after heart transplantation is not diminished among recipients with uncomplicated diabetes mellitus: an analysis of the United Network of Organ Sharing database..
114.
2006
-
T-cell immunity to subclinical cytomegalovirus infection reduces cardiac allograft disease..
114.
2006
-
Atrioventricular ring reentry in embryonic mouse hearts..
114.
2006
-
Adenoviral human BCL-2 transgene expression attenuates early donor cell death after cardiomyoblast transplantation into ischemic rat hearts..
114.
2006
-
Impact of internal mammary artery conduit on long-term outcomes after percutaneous intervention of saphenous vein graft..
114.
2006
-
Inhibition of Toll-like receptor 4 with eritoran attenuates myocardial ischemia-reperfusion injury..
114.
2006
-
Low-dose dobutamine tissue-tagged magnetic resonance imaging with 3-dimensional strain analysis allows assessment of myocardial viability in patients with ischemic cardiomyopathy..
114.
2006
-
Prediction of coronary heart disease in a population with high prevalence of diabetes and albuminuria: the Strong Heart Study..
113.
2006
-
Impact of diabetes mellitus on regression of electrocardiographic left ventricular hypertrophy and the prediction of outcome during antihypertensive therapy: the Losartan Intervention For Endpoint (LIFE) Reduction in Hypertension Study..
113.
2006
-
Advanced glycation end products activate a chymase-dependent angiotensin II-generating pathway in diabetic complications..
113.
2006
-
Integrated electroanatomic mapping with three-dimensional computed tomographic images for real-time guided ablations..
113.
2006
-
Electrocardiographic strain pattern and prediction of new-onset congestive heart failure in hypertensive patients: the Losartan Intervention for Endpoint Reduction in Hypertension (LIFE) study..
113.
2005
-
Decreased neurotrophin TrkB receptor expression reduces lesion size in the apolipoprotein E-null mutant mouse..
112.
2005
-
TLR2 and MyD88 contribute to Lactobacillus casei extract-induced focal coronary arteritis in a mouse model of Kawasaki disease..
112.
2005
-
Comparison of percutaneous coronary intervention and coronary artery bypass grafting after acute myocardial infarction complicated by cardiogenic shock: results from the Should We Emergently Revascularize Occluded Coronaries for Cardiogenic Shock (SHOCK) trial..
112.
2005
-
Metabolic imaging with beta-methyl-p-[(123)I]-iodophenyl-pentadecanoic acid identifies ischemic memory after demand ischemia..
112.
2005
-
Dimethylarginine dimethylaminohydrolase overexpression suppresses graft coronary artery disease..
112.
2005
-
Arterial versus venous bypass grafts in patients with in-stent restenosis..
112.
2005
-
Coronary artery bypass grafting in patients with low ejection fraction..
112.
2005
-
Embryonic stem cell immunogenicity increases upon differentiation after transplantation into ischemic myocardium..
112.
2005
-
Implantation in coronary circulation induces morphofunctional transformation of radial grafts from muscular to elastomuscular..
112.
2005
-
Novel injectable bioartificial tissue facilitates targeted, less invasive, large-scale tissue restoration on the beating heart after myocardial injury..
112.
2005
-
Surgical treatment of atrial fibrillation using argon-based cryoablation during concomitant cardiac procedures..
112.
2005
-
C-reactive protein as a predictor of cardiovascular risk in a population with a high prevalence of diabetes: the Strong Heart Study..
112.
2005
-
Reversal of cardiomyopathy in patients with repetitive monomorphic ventricular ectopy originating from the right ventricular outflow tract..
112.
2005
-
Targeted deletion of Fgl-2/fibroleukin in the donor modulates immunologic response and acute vascular rejection in cardiac xenografts..
112.
2005
-
Doppler estimation of left ventricular filling pressures in patients with mitral valve disease..
111.
2005
-
D-4F induces heme oxygenase-1 and extracellular superoxide dismutase, decreases endothelial cell sloughing, and improves vascular reactivity in rat model of diabetes..
111.
2005
-
Stimulation of paracrine pathways with growth factors enhances embryonic stem cell engraftment and host-specific differentiation in the heart after ischemic myocardial injury..
111.
2005
-
Body build and risk of cardiovascular events in hypertension and left ventricular hypertrophy: the LIFE (Losartan Intervention For Endpoint reduction in hypertension) study..
111.
2005
-
Overexpression of dimethylarginine dimethylaminohydrolase reduces tissue asymmetric dimethylarginine levels and enhances angiogenesis..
111.
2005
-
Cytokine preconditioning promotes codifferentiation of human fetal liver CD133+ stem cells into angiomyogenic tissue..
111.
2005
-
Vascular endothelial dysfunction and mortality risk in patients with chronic heart failure..
111.
2005
-
Functional interplay between the macrophage scavenger receptor class B type I and pitavastatin (NK-104)..
110.
2004
-
Adenoviral gene transfer with soluble vascular endothelial growth factor receptors impairs angiogenesis and perfusion in a murine model of hindlimb ischemia..
110.
2004
-
Regression of hypertensive left ventricular hypertrophy by losartan compared with atenolol: the Losartan Intervention for Endpoint Reduction in Hypertension (LIFE) trial..
110.
2004
-
Molecular imaging of the kinetics of vascular endothelial growth factor gene expression in ischemic myocardium..
110.
2004
-
Involvement of the serotonin 5-HT2B receptor in cardiac hypertrophy linked to sympathetic stimulation: control of interleukin-6, interleukin-1beta, and tumor necrosis factor-alpha cytokine production by ventricular fibroblasts..
110.
2004
-
Is the impact of hospital and surgeon volumes on the in-hospital mortality rate for coronary artery bypass graft surgery limited to patients at high risk?.
110.
2004
-
Association between platelet receptor occupancy after eptifibatide (integrilin) therapy and patency, myocardial perfusion, and ST-segment resolution among patients with ST-segment-elevation myocardial infarction: an INTEGRITI (Integrilin and Tenecteplase in Acute Myocardial Infarction) substudy..
110.
2004
-
Altered titin expression, myocardial stiffness, and left ventricular function in patients with dilated cardiomyopathy..
110.
2004
-
Neurological events during long-term mechanical circulatory support for heart failure: the Randomized Evaluation of Mechanical Assistance for the Treatment of Congestive Heart Failure (REMATCH) experience..
109.
2004
-
Optimal noninvasive assessment of left ventricular filling pressures: a comparison of tissue Doppler echocardiography and B-type natriuretic peptide in patients with pulmonary artery catheters..
109.
2004
-
Propensity analysis of long-term survival after surgical or percutaneous revascularization in patients with multivessel coronary artery disease and high-risk features..
109.
2004
-
Non-polymer-based paclitaxel-coated coronary stents for the treatment of patients with de novo coronary lesions: angiographic follow-up of the DELIVER clinical trial..
109.
2004
-
Characterization of left ventricular diastolic function by tissue Doppler imaging and clinical status in children with hypertrophic cardiomyopathy..
109.
2004
-
Targeted anticytokine therapy in patients with chronic heart failure: results of the Randomized Etanercept Worldwide Evaluation (RENEWAL)..
109.
2004
-
Developmental endothelial locus-1 (Del-1), a novel angiogenic protein: its role in ischemia..
109.
2004
-
Pitavastatin downregulates expression of the macrophage type B scavenger receptor, CD36..
109.
2004
-
Relationship of high and low ankle brachial index to all-cause and cardiovascular disease mortality: the Strong Heart Study..
109.
2004
-
Predictors of outcome after alcohol septal ablation therapy in patients with hypertrophic obstructive cardiomyopathy..
109.
2004
-
Analysis of 1-year clinical outcomes in the SIRIUS trial: a randomized trial of a sirolimus-eluting stent versus a standard stent in patients at high risk for coronary restenosis..
109.
2004
-
Differential treatment benefit of platelet glycoprotein IIb/IIIa inhibition with percutaneous coronary intervention versus medical therapy for acute coronary syndromes: exploration of methods..
109.
2004
-
Images in cardiovascular medicine. Avoiding papillary muscle infarction with myocardial contrast echocardiographic guidance of nonsurgical septal reduction therapy for hypertrophic obstructive cardiomyopathy..
109.
2004
-
Cytomegalovirus infection impairs the nitric oxide synthase pathway: role of asymmetric dimethylarginine in transplant arteriosclerosis..
109.
2004
-
Dimethylarginine dimethylaminohydrolase regulates nitric oxide synthesis: genetic and physiological evidence..
108.
2003
-
Anatomic stereotactic catheter ablation on three-dimensional magnetic resonance images in real time..
108.
2003
-
Gadolinium cardiovascular magnetic resonance predicts reversible myocardial dysfunction and remodeling in patients with heart failure undergoing beta-blocker therapy..
108.
2003
-
Effects of eplerenone, enalapril, and eplerenone/enalapril in patients with essential hypertension and left ventricular hypertrophy: the 4E-left ventricular hypertrophy study..
108.
2003
-
The -174G/C interleukin-6 polymorphism influences postoperative interleukin-6 levels and postoperative atrial fibrillation. Is atrial fibrillation an inflammatory complication?.
108 Suppl 1.
2003
-
Long-term results of the radial artery used for myocardial revascularization..
108.
2003
-
Cardiology patient page. Antiplatelet therapy..
108.
2003
-
Safety of an aspirin-alone regimen after intracoronary stenting with a heparin-coated stent: final results of the HOPE (HEPACOAT and an Antithrombotic Regimen of Aspirin Alone) study..
108.
2003
-
Antioxidant vitamins C and E improve endothelial function in children with hyperlipidemia: Endothelial Assessment of Risk from Lipids in Youth (EARLY) Trial..
108.
2003
-
Endothelial dysfunction induced by hyperhomocyst(e)inemia: role of asymmetric dimethylarginine..
108.
2003
-
Do hospitals and surgeons with higher coronary artery bypass graft surgery volumes still have lower risk-adjusted mortality rates?.
108.
2003
-
Regression of electrocardiographic left ventricular hypertrophy by losartan versus atenolol: The Losartan Intervention for Endpoint reduction in Hypertension (LIFE) Study..
108.
2003
-
Randomized, double-blind, placebo-controlled, international trial of the oral IIb/IIIa antagonist lotrafiban in coronary and cerebrovascular disease..
108.
2003
-
Tissue Doppler imaging predicts the development of hypertrophic cardiomyopathy in subjects with subclinical disease..
108.
2003
-
Spatial distribution of phase singularities in ventricular fibrillation..
108.
2003
-
Overexpression of the serotonin 5-HT2B receptor in heart leads to abnormal mitochondrial function and cardiac hypertrophy..
107.
2003
-
Risks of using internal thoracic artery grafts in patients in chronic hemodialysis via upper extremity arteriovenous fistula..
107.
2003
-
Low-density lipoprotein in hypercholesterolemic human plasma induces vascular endothelial cell apoptosis by inhibiting fibroblast growth factor 2 transcription..
107.
2003
-
Cardiovascular morbidity and mortality in women diagnosed with rheumatoid arthritis..
107.
2003
-
Beating atrial septal defect closure monitored by epicardial real-time three-dimensional echocardiography without cardiopulmonary bypass..
107.
2003
-
Identification of hibernating myocardium with quantitative intravenous myocardial contrast echocardiography: comparison with dobutamine echocardiography and thallium-201 scintigraphy..
107.
2003
-
Nicotine strongly activates dendritic cell-mediated adaptive immunity: potential role for progression of atherosclerotic lesions..
107.
2003
-
Echocardiographic predictors of survival and response to early revascularization in cardiogenic shock..
107.
2003
-
Vascular structural and functional changes in type 2 diabetes mellitus: evidence for the roles of abnormal myogenic responsiveness and dyslipidemia..
106.
2002
-
Response to adenosine differentiates focal from macroreentrant atrial tachycardia: validation using three-dimensional electroanatomic mapping..
106.
2002
-
Long-term outcome of patients treated with repeat percutaneous coronary intervention after failure of gamma-brachytherapy for the treatment of in-stent restenosis..
106.
2002
-
Randomized COMparison of platelet inhibition with abciximab, tiRofiban and eptifibatide during percutaneous coronary intervention in acute coronary syndromes: the COMPARE trial. Comparison Of Measurements of Platelet aggregation with Aggrastat, Reopro, and Eptifibatide..
106.
2002
-
Impaired nitric oxide synthase pathway in diabetes mellitus: role of asymmetric dimethylarginine and dimethylarginine dimethylaminohydrolase..
106.
2002
-
Microvascular structural correlates of myocardial contrast echocardiography in patients with coronary artery disease and left ventricular dysfunction: implications for the assessment of myocardial hibernation..
106.
2002
-
Prognostic implications of abnormalities in renal function in patients with acute coronary syndromes..
106.
2002
-
Acute effect of nonsurgical septal reduction therapy on regional left ventricular asynchrony in patients with hypertrophic obstructive cardiomyopathy..
106.
2002
-
Change in systolic left ventricular performance after 3 years of antihypertensive treatment: the Losartan Intervention for Endpoint (LIFE) Study..
106.
2002
-
First experience with direct factor Xa inhibition in patients with stable coronary disease: a pharmacokinetic and pharmacodynamic evaluation..
105.
2002
-
Mitral ratio of peak early to late diastolic filling velocity as a predictor of mortality in middle-aged and elderly adults: the Strong Heart Study..
105.
2002
-
Percutaneous left atrial appendage transcatheter occlusion to prevent stroke in high-risk patients with atrial fibrillation: early clinical experience..
105.
2002
-
Myocardial fibrosis in chronic aortic regurgitation: molecular and cellular responses to volume overload..
105.
2002
-
Plasma homocysteine concentration, statin therapy, and the risk of first acute coronary events..
105.
2002
-
Markers of increased risk of intracerebral hemorrhage after intravenous recombinant tissue plasminogen activator therapy for acute ischemic stroke in clinical practice: the Multicenter rt-PA Stroke Survey..
105.
2002
-
Increased myocardial gene expression of tumor necrosis factor-alpha and nitric oxide synthase-2: a potential mechanism for depressed myocardial function in hibernating myocardium in humans..
105.
2002
-
Change in diastolic left ventricular filling after one year of antihypertensive treatment: The Losartan Intervention For Endpoint Reduction in Hypertension (LIFE) Study..
105.
2002
-
Pharmacological treatment of coronary artery disease with recombinant fibroblast growth factor-2: double-blind, randomized, controlled clinical trial..
105.
2002
-
Principal component analysis of the T wave and prediction of cardiovascular mortality in American Indians: the Strong Heart Study..
105.
2002
-
Statins have biphasic effects on angiogenesis..
105.
2002
-
Minor myocardial damage and prognosis: are spontaneous and percutaneous coronary intervention-related events different?.
105.
2002
-
Platelet-derived growth factor-AB limits the extent of myocardial infarction in a rat model: feasibility of restoring impaired angiogenic capacity in the aging heart..
105.
2002
-
Noninvasive assessment of coronary microcirculatory function in postmenopausal women and effects of short-term and long-term estrogen administration..
105.
2002
-
Outcomes of patients with acute coronary syndromes and prior coronary artery bypass grafting: results from the platelet glycoprotein IIb/IIIa in unstable angina: receptor suppression using integrilin therapy (PURSUIT) trial..
105.
2002
-
Plasma leptin and the risk of cardiovascular disease in the west of Scotland coronary prevention study (WOSCOPS)..
104.
2001
-
Adenovirus-mediated heme oxygenase-1 gene delivery inhibits injury-induced vascular neointima formation..
104.
2001
-
beta-blockers before percutaneous coronary intervention do not attenuate postprocedural creatine kinase isoenzyme rise..
104.
2001
-
Homocysteine impairs the nitric oxide synthase pathway: role of asymmetric dimethylarginine..
104.
2001
-
Allopurinol improves myocardial efficiency in patients with idiopathic dilated cardiomyopathy..
104.
2001
-
Novel cardiac troponin T mutation as a cause of familial dilated cardiomyopathy..
104.
2001
-
Clinical and angiographic effects of chronic calcium channel blocker therapy continued beyond first postoperative year in patients with radial artery grafts: results of a prospective randomized investigation..
104.
2001
-
Effects of once-daily angiotensin-converting enzyme inhibition and calcium channel blockade-based antihypertensive treatment regimens on left ventricular hypertrophy and diastolic filling in hypertension: the prospective randomized enalapril study evaluating regression of ventricular enlargement (preserve) trial..
104.
2001
-
Heterogeneous expression of Gap junction channels in the heart leads to conduction defects and ventricular dysfunction..
104.
2001
-
Abciximab readministration: results of the ReoPro Readministration Registry..
104.
2001
-
Adenovirus-mediated gene transfer of VEGF(121) improves lower-extremity endothelial function and flow reserve..
104.
2001
-
Left ventricular remodeling in transgenic mice with cardiac restricted overexpression of tumor necrosis factor..
104.
2001
-
Cardiac hypertrophy after transplantation is associated with persistent expression of tumor necrosis factor-alpha..
104.
2001
-
Comparison of right and left ventricular responses to left ventricular assist device support in patients with severe heart failure: a primary role of mechanical unloading underlying reverse remodeling..
104.
2001
-
Development and testing of the Helex septal occluder, a new expanded polytetrafluoroethylene atrial septal defect occlusion system..
104.
2001
-
Mechanoelectrical feedback: role of beta-adrenergic receptor activation in mediating load-dependent shortening of ventricular action potential and refractoriness..
104.
2001
-
Pharmacodynamics and pharmacokinetics of eptifibatide in patients with acute coronary syndromes: prospective analysis from PURSUIT..
104.
2001
-
Pharmacodynamics and pharmacokinetics of higher-dose, double-bolus eptifibatide in percutaneous coronary intervention..
104.
2001
-
Simvastatin induces regression of cardiac hypertrophy and fibrosis and improves cardiac function in a transgenic rabbit model of human hypertrophic cardiomyopathy..
104.
2001
-
Tissue Doppler imaging consistently detects myocardial abnormalities in patients with hypertrophic cardiomyopathy and provides a novel means for an early diagnosis before and independently of hypertrophy..
104.
2001
-
Identification of a chromosome 11q23.2-q24 locus for familial aortic aneurysm disease, a genetically heterogeneous disorder..
103.
2001
-
Controlled trial of intravenous immune globulin in recent-onset dilated cardiomyopathy..
103.
2001
-
Long-term effects of intracoronary beta-radiation in balloon- and stent-injured porcine coronary arteries..
103.
2001
-
Decreased expression of tumor necrosis factor-alpha and regression of hypertrophy after nonsurgical septal reduction therapy for patients with hypertrophic obstructive cardiomyopathy..
103.
2001
-
Regression of left ventricular hypertrophy after nonsurgical septal reduction therapy for hypertrophic obstructive cardiomyopathy..
103.
2001
-
Deceleration time in ischemic cardiomyopathy: relation to echocardiographic and scintigraphic indices of myocardial viability and functional recovery after revascularization..
103.
2001
-
Results of targeted anti-tumor necrosis factor therapy with etanercept (ENBREL) in patients with advanced heart failure..
103.
2001
-
Transforming growth factor-beta(1) stimulates L-arginine transport and metabolism in vascular smooth muscle cells: role in polyamine and collagen synthesis..
103.
2001
-
Hemodynamic effects of tezosentan, an intravenous dual endothelin receptor antagonist, in patients with class III to IV congestive heart failure..
103.
2001
-
Relations of stroke volume and cardiac output to body composition: the strong heart study..
103.
2001
-
Effect of type 2 diabetes mellitus on left ventricular geometry and systolic function in hypertensive subjects: Hypertension Genetic Epidemiology Network (HyperGEN) study..
103.
2001
-
Enhanced efficacy of eptifibatide administration in patients with acute coronary syndrome requiring in-hospital coronary artery bypass grafting. PURSUIT Investigators..
102.
2000
-
Chronic unloading by left ventricular assist device reverses contractile dysfunction and alters gene expression in end-stage heart failure..
102.
2000
-
Altered adrenergic receptor density in myocardial hibernation in humans: A possible mechanism of depressed myocardial function..
102.
2000
-
Rapid and efficient vascular transport of arginine polymers inhibits myointimal hyperplasia..
102.
2000
-
Photoangioplasty for human peripheral atherosclerosis: results of a phase I trial of photodynamic therapy with motexafin lutetium (Antrin)..
102.
2000
-
Angiotensin II receptor subtypes in the skeletal muscle vasculature of patients with severe congestive heart failure..
102.
2000
-
American College of Cardiology/American Heart Association Clinical Competence Statement on Stress Testing. A Report of the American College of Cardiology/American Heart Association/American College of Physicians-American Society of Internal Medicine Task Force on Clinical Competence..
102.
2000
-
The unclampable ascending aorta in coronary artery bypass patients: A surgical challenge of increasing frequency..
102.
2000
-
Angiogenesis is impaired by hypercholesterolemia: role of asymmetric dimethylarginine..
102.
2000
-
Tissue Doppler imaging consistently detects myocardial contraction and relaxation abnormalities, irrespective of cardiac hypertrophy, in a transgenic rabbit model of human hypertrophic cardiomyopathy..
102.
2000
-
Clinical and therapeutic profile of patients presenting with acute coronary syndromes who do not have significant coronary artery disease.The Platelet Glycoprotein IIb/IIIa in Unstable Angina: Receptor Suppression Using Integrilin Therapy (PURSUIT) Trial Investigators..
102.
2000
-
Management of patients with acute coronary syndromes in the United States by platelet glycoprotein IIb/IIIa inhibition. Insights from the platelet glycoprotein IIb/IIIa in unstable angina: receptor suppression using integrilin therapy (PURSUIT) trial..
102.
2000
-
Dose-finding, safety, and tolerability study of an oral platelet glycoprotein IIb/IIIa inhibitor, lotrafiban, in patients with coronary or cerebral atherosclerotic disease..
102.
2000
-
Pronounced benefit of coronary stenting and adjunctive platelet glycoprotein IIb/IIIa inhibition in complex atherosclerotic lesions..
102.
2000
-
High levels of platelet inhibition with abciximab despite heightened platelet activation and aggregation during thrombolysis for acute myocardial infarction: results from TIMI (thrombolysis in myocardial infarction) 14..
101.
2000
-
Predictors of outcome in patients with acute coronary syndromes without persistent ST-segment elevation. Results from an international trial of 9461 patients. The PURSUIT Investigators..
101.
2000
-
Impact of diabetes on cardiac structure and function: the strong heart study..
101.
2000
-
Transthoracic cardioversion of atrial fibrillation: comparison of rectilinear biphasic versus damped sine wave monophasic shocks..
101.
2000
-
Effects of abciximab, ticlopidine, and combined Abciximab/Ticlopidine therapy on platelet and leukocyte function in patients undergoing coronary angioplasty..
101.
2000
-
Myocardial infarction in treated hypertensive patients: the paradox of lower incidence but higher mortality in young blacks compared with whites..
101.
2000
-
Identification of patients at increased risk of first unheralded acute myocardial infarction by electron-beam computed tomography..
101.
2000
-
Early percutaneous coronary intervention, platelet inhibition with eptifibatide, and clinical outcomes in patients with acute coronary syndromes. PURSUIT Investigators..
101.
2000
-
Left ventricular geometry and function preceding neurally mediated syncope..
101.
2000
-
Relation between baseline and on-treatment lipid parameters and first acute major coronary events in the Air Force/Texas Coronary Atherosclerosis Prevention Study (AFCAPS/TexCAPS)..
101.
2000
-
Severity of coronary artery calcification by electron beam computed tomography predicts silent myocardial ischemia..
101.
2000
-
Relation of left ventricular diastolic properties to systolic function in arterial hypertension..
101.
2000
-
Assessment of QT interval and QT dispersion for prediction of all-cause and cardiovascular mortality in American Indians: The Strong Heart Study..
101.
2000
-
Risk factors, angiographic patterns, and outcomes in patients with ventricular septal defect complicating acute myocardial infarction. GUSTO-I (Global Utilization of Streptokinase and TPA for Occluded Coronary Arteries) Trial Investigators..
101.
2000
-
Optimizing the percutaneous interventional outcomes for patients with diabetes mellitus: results of the EPISTENT (Evaluation of platelet IIb/IIIa inhibitor for stenting trial) diabetic substudy..
100.
1999
-
Identification of optimal conditions for lung graft storage with Euro-Collins solution by use of a rat orthotopic lung transplant model..
100.
1999
-
Local L-arginine delivery after balloon angioplasty reduces monocyte binding and induces apoptosis..
100.
1999
-
Role of papillary muscle in the generation and maintenance of reentry during ventricular tachycardia and fibrillation in isolated swine right ventricle..
100.
1999
-
Decreased expression of tumor necrosis factor-alpha in failing human myocardium after mechanical circulatory support : A potential mechanism for cardiac recovery..
100.
1999
-
Mononuclear cell adherence to cultured endothelium is enhanced by hypertension and insulin resistance in healthy nondiabetic volunteers..
100.
1999
-
Angiogenesis gene therapy: phase I assessment of direct intramyocardial administration of an adenovirus vector expressing VEGF121 cDNA to individuals with clinically significant severe coronary artery disease..
100.
1999
-
Desmin mutation responsible for idiopathic dilated cardiomyopathy..
100.
1999
-
Relation of the contractile reserve of hibernating myocardium to myocardial structure in humans..
100.
1999
-
Simultaneous multisite mapping of the right and the left atrial septum in the canine intact beating heart..
100.
1999
-
Novel mechanism for endothelial dysfunction: dysregulation of dimethylarginine dimethylaminohydrolase..
99.
1999
-
Clinical significance of thrombocytopenia during a non-ST-elevation acute coronary syndrome. The platelet glycoprotein IIb/IIIa in unstable angina: receptor suppression using integrilin therapy (PURSUIT) trial experience..
99.
1999
-
Prevalence of myocardial viability as detected by positron emission tomography in patients with ischemic cardiomyopathy..
99.
1999
-
Abciximab facilitates the rate and extent of thrombolysis: results of the thrombolysis in myocardial infarction (TIMI) 14 trial. The TIMI 14 Investigators..
99.
1999
-
Multicenter clinical trial to evaluate the efficacy of correction for photon attenuation and scatter in SPECT myocardial perfusion imaging..
99.
1999
-
Rising tide of cardiovascular disease in American Indians. The Strong Heart Study..
99.
1999
-
Stroke in patients with acute coronary syndromes: incidence and outcomes in the platelet glycoprotein IIb/IIIa in unstable angina. Receptor suppression using integrilin therapy (PURSUIT) trial. The PURSUIT Investigators..
99.
1999
-
Sustained suppression of ischemic complications of coronary intervention by platelet GP IIb/IIIa blockade with abciximab: one-year outcome in the EPILOG trial. Evaluation in PTCA to Improve Long-term Outcome with abciximab GP IIb/IIIa blockade..
99.
1999
-
Cellular effects of beta-particle delivery on vascular smooth muscle cells and endothelial cells: a dose-response study..
99.
1999
-
Induction of neurally mediated syncope with adenosine..
99.
1999
-
Endogenous nitric oxide synthase inhibitor: a novel marker of atherosclerosis..
99.
1999
-
Regression of atherosclerosis: role of nitric oxide and apoptosis..
99.
1999
-
Influence of low HDL on progression of coronary artery disease and response to fluvastatin therapy..
99.
1999
-
L-Arginine normalizes coronary vasomotion in long-term smokers..
99.
1999
-
Changes in left ventricular diastolic function 6 months after nonsurgical septal reduction therapy for hypertrophic obstructive cardiomyopathy..
99.
1999
-
Doppler estimation of left ventricular filling pressures in patients with hypertrophic cardiomyopathy..
99.
1999
-
Long-term prognostic value of exercise echocardiography compared with exercise 201Tl, ECG, and clinical variables in patients evaluated for coronary artery disease..
98.
1998
-
Relations of left ventricular mass to fat-free and adipose body mass: the strong heart study. The Strong Heart Study Investigators..
98.
1998
-
TNK-tissue plasminogen activator compared with front-loaded alteplase in acute myocardial infarction: results of the TIMI 10B trial. Thrombolysis in Myocardial Infarction (TIMI) 10B Investigators..
98.
1998
-
Evidence for unconscious memory processing during elective cardiac surgery..
98.
1998
-
Intensive medical therapy versus coronary angioplasty for suppression of myocardial ischemia in survivors of acute myocardial infarction: a prospective, randomized pilot study..
98.
1998
-
Asymmetric dimethylarginine (ADMA): a novel risk factor for endothelial dysfunction: its role in hypercholesterolemia..
98.
1998
-
Echocardiography-guided ethanol septal reduction for hypertrophic obstructive cardiomyopathy..
98.
1998
-
Doppler estimation of left ventricular filling pressure in sinus tachycardia. A new application of tissue doppler imaging..
98.
1998
-
Pharmacodynamic efficacy, clinical safety, and outcomes after prolonged platelet Glycoprotein IIb/IIIa receptor blockade with oral xemilofiban: results of a multicenter, placebo-controlled, randomized trial..
98.
1998
-
Randomized, placebo-controlled trial of platelet glycoprotein IIb/IIIa blockade with primary angioplasty for acute myocardial infarction. ReoPro and Primary PTCA Organization and Randomized Trial (RAPPORT) Investigators..
98.
1998
-
Limb blood flow during exercise is dependent on nitric oxide..
98.
1998
-
Effects of long-term smoking on myocardial blood flow, coronary vasomotion, and vasodilator capacity..
98.
1998
-
Induction of cyclooxygenase-2 and activation of nuclear factor-kappaB in myocardium of patients with congestive heart failure..
98.
1998
-
The cost-effectiveness of automatic implantable cardiac defibrillators: results from MADIT. Multicenter Automatic Defibrillator Implantation Trial..
97.
1998
-
Transdermal nitroglycerin patch therapy improves left ventricular function and prevents remodeling after acute myocardial infarction: results of a multicenter prospective randomized, double-blind, placebo-controlled trial..
97.
1998
-
Diabetes mellitus, glycoprotein IIb/IIIa blockade, and heparin: evidence for a complex interaction in a multicenter trial. EPILOG Investigators..
97.
1998
-
Prediction of indications for valve replacement among asymptomatic or minimally symptomatic patients with chronic aortic regurgitation and normal left ventricular performance..
97.
1998
-
Three-dimensional electrophysiological imaging of the intact canine left ventricle using a noncontact multielectrode cavitary probe: study of sinus, paced, and spontaneous premature beats..
97.
1998
-
Circulating adhesion molecules VCAM-1, ICAM-1, and E-selectin in carotid atherosclerosis and incident coronary heart disease cases: the Atherosclerosis Risk In Communities (ARIC) study..
96.
1997
-
Assessment of myocardial viability with 99mTc-sestamibi tomography before coronary bypass graft surgery: correlation with histopathology and postoperative improvement in cardiac function..
96.
1997
-
Channel patency and neovascularization after transmyocardial revascularization using an excimer laser: results and comparisons to nonlased channels..
96.
1997
-
Heart rate adjustment of exercise-induced ST-segment depression identifies men who benefit from a risk factor reduction program..
96.
1997
-
Impact of minimum hematocrit during cardiopulmonary bypass on mortality in patients undergoing coronary artery surgery..
96.
1997
-
Relations of left ventricular mass to demographic and hemodynamic variables in American Indians: the Strong Heart Study..
96.
1997
-
Adenosine-sensitive ventricular tachycardia: right ventricular abnormalities delineated by magnetic resonance imaging..
96.
1997
-
Sustained platelet glycoprotein IIb/IIIa blockade with oral xemilofiban in 170 patients after coronary stent deployment..
96.
1997
-
Nitric oxide regulates monocyte chemotactic protein-1..
96.
1997
-
Inhibition of vascular smooth muscle cell proliferation and neointimal accumulation by adenovirus-mediated gene transfer of cytosine deaminase..
96.
1997
-
Intracoronary Doppler assessment of moderate coronary artery disease: comparison with 201Tl imaging and coronary angiography. FACTS Study Group..
96.
1997
-
High-dose heparin decreases nitric oxide production by cultured bovine endothelial cells..
95.
1997
-
Local intramural delivery of L-arginine enhances nitric oxide generation and inhibits lesion formation after balloon angioplasty..
95.
1997
-
Nitroglycerin-augmented 201T1 reinjection enhances detection of reversible myocardial hypoperfusion. A randomized, double-blind, parallel, placebo-controlled trial..
95.
1997
-
Stroke volume and cardiac output in normotensive children and adults. Assessment of relations with body size and impact of overweight..
95.
1997
-
Vasopressin deficiency contributes to the vasodilation of septic shock..
95.
1997
-
Combined accelerated tissue-plasminogen activator and platelet glycoprotein IIb/IIIa integrin receptor blockade with Integrilin in acute myocardial infarction. Results of a randomized, placebo-controlled, dose-ranging trial. IMPACT-AMI Investigators..
95.
1997
-
Dobutamine echocardiography and quantitative rest-redistribution 201Tl tomography in myocardial hibernation. Relation of contractile reserve to 201Tl uptake and comparative prediction of recovery of function..
95.
1997
-
Continuous subcutaneous angiopeptin treatment significantly reduces neointimal hyperplasia in a porcine coronary in-stent restenosis model..
95.
1997
-
Chronotropic response to exercise. Improved performance of ST-segment depression criteria after adjustment for heart rate reserve..
94.
1996
-
Mechanism of ventricular rate control after radiofrequency modification of atrioventricular conduction in patients with atrial fibrillation..
94.
1996
-
Prognostic value of exercise 201Tl tomography in patients treated with thrombolytic therapy during acute myocardial infarction..
94.
1996
-
Distinct effects of recombinant desulfatohirudin (Revasc) and heparin on plasma levels of fibrinopeptide A and prothrombin fragment F1.2 in unstable angina. A multicenter trial..
94.
1996
-
Assessment of left ventricular filling pressures by Doppler in the presence of atrial fibrillation..
94.
1996
-
Effects of integrelin, a platelet glycoprotein IIb/IIIa receptor antagonist, in unstable angina. A randomized multicenter trial..
94.
1996
-
Age and outcome with contemporary thrombolytic therapy. Results from the GUSTO-I trial. Global Utilization of Streptokinase and TPA for Occluded coronary arteries trial..
94.
1996
-
Recombinant mitotoxin basic fibroblast growth factor-saporin reduces venous anastomotic intimal hyperplasia in the arteriovenous graft..
94.
1996
-
Fluid flow inhibits endothelial adhesiveness. Nitric oxide and transcriptional regulation of VCAM-1..
94.
1996
-
Assessment of myocardial viability with 99mTc sestamibi in patients undergoing cardiac transplantation. A scintigraphic/pathological study..
94.
1996
-
Differential dose-response to oral xemilofiban after antecedent intravenous abciximab. Administration for complex coronary intervention..
94.
1996
-
Arterial remodeling after coronary angioplasty: a serial intravascular ultrasound study..
94.
1996
-
Impaired heart rate response to graded exercise. Prognostic implications of chronotropic incompetence in the Framingham Heart Study..
93.
1996
-
Levels of soluble cell adhesion molecules in patients with dyslipidemia..
93.
1996
-
Expression of inducible nitric oxide synthase in human heart failure..
93.
1996
-
Relation of mean right atrial pressure to echocardiographic and Doppler parameters of right atrial and right ventricular function..
93.
1996
-
Induction of nitric oxide synthase in the human cardiac allograft is associated with contractile dysfunction of the left ventricle..
93.
1996
-
Tumor necrosis factor-alpha and tumor necrosis factor receptors in the failing human heart..
93.
1996
-
Midwall left ventricular mechanics. An independent predictor of cardiovascular risk in arterial hypertension..
93.
1996
-
Exposure to shear stress alters endothelial adhesiveness. Role of nitric oxide..
92.
1995
-
Localization of a gene responsible for familial dilated cardiomyopathy to chromosome 1q32..
92.
1995
-
Ischemia-induced interleukin-8 release after human heart transplantation. A potential role for endothelial cells..
92.
1995
-
Angiotensin-I converting enzyme genotypes and left ventricular hypertrophy in patients with hypertrophic cardiomyopathy..
92.
1995
-
Double-blind, placebo-controlled study of the long-term efficacy of carvedilol in patients with severe chronic heart failure..
92.
1995
-
Expression and functional significance of tumor necrosis factor receptors in human myocardium..
92.
1995
-
Fibrinolysis inhibits shear stress-induced platelet aggregation..
92.
1995
-
Gender-specific criteria and performance of the exercise electrocardiogram..
92.
1995
-
Mechanism of repetitive monomorphic ventricular tachycardia..
92.
1995
-
Effects of long-term enalapril therapy on cardiac structure and function in patients with left ventricular dysfunction. Results of the SOLVD echocardiography substudy..
91.
1995
-
Vascular smooth muscle cell heme oxygenases generate guanylyl cyclase-stimulatory carbon monoxide..
91.
1995
-
Multicenter, randomized, double-blind, placebo-controlled trial of the platelet integrin glycoprotein IIb/IIIa blocker Integrelin in elective coronary intervention. IMPACT Investigators..
91.
1995
-
Rebound increase in thrombin generation and activity after cessation of intravenous heparin in patients with acute coronary syndromes..
91.
1995
-
Comparative real-time effects on platelet adhesion and aggregation under flowing conditions of in vivo aspirin, heparin, and monoclonal antibody fragment against glycoprotein IIb-IIIa..
91.
1995
-
Shear-induced platelet aggregation is inhibited by in vivo infusion of an anti-glycoprotein IIb/IIIa antibody fragment, c7E3 Fab, in patients undergoing coronary angioplasty..
91.
1995
-
Dobutamine echocardiography in myocardial hibernation. Optimal dose and accuracy in predicting recovery of ventricular function after coronary angioplasty..
91.
1995
-
Fractal clustering of ventricular ectopy correlates with sympathetic tone preceding ectopic beats..
91.
1995
-
Metabolic determinants of defibrillation. Role of adenosine..
91.
1995
-
Comparison of clinical and angiographic outcomes after saphenous vein graft angioplasty using coronary versus 'biliary' tubular slotted stents..
91.
1995
-
Mortality within 24 hours of thrombolysis for myocardial infarction. The importance of early reperfusion. The GUSTO Investigators, Global Utilization of Streptokinase and Tissue Plasminogen Activator for Occluded Coronary Arteries..
90.
1994
-
Role of arterial chemoreceptors in mediating the effects of endogenous adenosine on sympathetic nerve activity..
90.
1994
-
Inhibition of platelet deposition and lysis of intracoronary thrombus during balloon angioplasty using urokinase-coated hydrogel balloons..
90.
1994
-
Pharmacodynamics of chimeric glycoprotein IIb/IIIa integrin antiplatelet antibody Fab 7E3 in high-risk coronary angioplasty..
90.
1994
-
Indirect angiogenic cytokines upregulate VEGF and bFGF gene expression in vascular smooth muscle cells, whereas hypoxia upregulates VEGF expression only..
90.
1994
-
Impact of age on clinical outcome and postlytic management strategies in patients treated with intravenous thrombolytic therapy. Results from the TIMI II Study. TIMI II Investigators..
90.
1994
-
Mechanism-specific effects of adenosine on atrial tachycardia..
89.
1994
-
Enhanced endothelial adhesiveness in hypercholesterolemia is attenuated by L-arginine..
89.
1994
-
Effect of L-arginine on coronary endothelial function in cardiac transplant recipients. Relation to vessel wall morphology..
89.
1994
-
Recombinant hirudin for unstable angina pectoris. A multicenter, randomized angiographic trial..
89.
1994
-
Vascular injury augments adrenergic neurotransmission..
89.
1994
-
Combination antithrombotic therapy in unstable rest angina and non-Q-wave infarction in nonprior aspirin users. Primary end points analysis from the ATACS trial. Antithrombotic Therapy in Acute Coronary Syndromes Research Group..
89.
1994
-
Efficient and selective adenovirus-mediated gene transfer into vascular neointima..
88.
1993
-
Selective pulmonary vasodilation by inhaled nitric oxide is due to hemoglobin inactivation..
88.
1993
-
Value of the P-wave signal-averaged ECG for predicting atrial fibrillation after cardiac surgery..
88.
1993
-
Can further benefit be achieved by adding flosequinan to patients with congestive heart failure who remain symptomatic on diuretic, digoxin, and an angiotensin converting enzyme inhibitor? Results of the flosequinan-ACE inhibitor trial (FACET)..
88.
1993
-
Prognostic value and physiological correlates of heart rate variability in chronic severe mitral regurgitation..
88.
1993
-
Shear stress elevates endothelial cGMP. Role of a potassium channel and G protein coupling..
88.
1993
-
Angiographic and hemodynamic determinants of myocardial ischemia during adenosine thallium-201 scintigraphy in coronary artery disease..
87.
1993
-
Quantitative adenosine 201Tl single-photon emission computed tomography for the early assessment of patients surviving acute myocardial infarction..
87.
1993
-
Response of nonreentrant catecholamine-mediated ventricular tachycardia to endogenous adenosine and acetylcholine. Evidence for myocardial receptor-mediated effects..
87.
1993
-
Parallel cardiac and vascular adaptation in hypertension..
86.
1992
-
Exercise echocardiography versus 201Tl single-photon emission computed tomography in evaluation of coronary artery disease. Analysis of 292 patients..
85.
1992
-
Doppler echocardiographic evaluation of pseudoaneurysms complicating composite grafts of the ascending aorta..
85.
1992
-
Natural history of left ventricular performance at rest and during exercise after aortic valve replacement for aortic regurgitation..
84.
1991
-
Efficacy of permanent pacing in the management of high-risk patients with long QT syndrome..
84.
1991
-
Hypercholesterolemia enhances macrophage recruitment and dysfunction of regenerated endothelium after balloon injury of the rabbit iliac artery..
84.
1991
-
Effect of ST segment measurement point on performance of standard and heart rate-adjusted ST segment criteria for the identification of coronary artery disease..
84.
1991
-
Arginine restores cholinergic relaxation of hypercholesterolemic rabbit thoracic aorta..
83.
1991
-
Heart rate adjustment of exercise-induced ST segment depression. Improved risk stratification in the Framingham Offspring Study..
83.
1991
-
Doppler echocardiographic assessment of the St. Jude Medical prosthetic valve in the aortic position using the continuity equation..
83.
1991
-
Sex differences in control of cutaneous blood flow..
82.
1990
-
Treatment with desmopressin acetate in routine coronary artery bypass surgery to improve postoperative hemostasis..
82.
1990
-
Altered myocardial perfusion in patients with angina pectoris or silent ischemia during exercise as assessed by quantitative thallium-201 single-photon emission computed tomography..
82.
1990
-
Doppler assessment of right ventricular filling in a normal population. Comparison with left ventricular filling dynamics..
82.
1990
-
Intravenous recombinant tissue-type plasminogen activator in patients with unstable angina pectoris. Results of a placebo-controlled, randomized trial..
82.
1990
-
Diagnosis of coronary artery disease by controlled coronary vasodilation with adenosine and thallium-201 scintigraphy in patients unable to exercise..
82.
1990
-
Persistent dysfunction of regenerated endothelium after balloon angioplasty of rabbit iliac artery..
81.
1990
-
Effect of epicardial patch electrodes on transthoracic defibrillation..
81.
1990
-
Electrophysiological effects of adenosine in the transplanted human heart. Evidence of supersensitivity..
81.
1990
-
Lack of diurnal variation in the onset of non-Q wave infarction..
81.
1990
-
Relation of blood viscosity to demographic and physiologic variables and to cardiovascular risk factors in apparently normal adults..
81.
1990
-
Relation of left ventricular hemodynamic load and contractile performance to left ventricular mass in hypertension..
81.
1990
-
Electrophysiologic effects of dipyridamole on atrioventricular nodal conduction and supraventricular tachycardia. Role of endogenous adenosine..
80.
1989
-
Feasibility of tomographic 99mTc-hexakis-2-methoxy-2-methylpropyl-isonitrile imaging for the assessment of myocardial area at risk and the effect of treatment in acute myocardial infarction..
80.
1989
-
Mitral valve dimensions and motion in Marfan patients with and without mitral valve prolapse. Comparison to primary mitral valve prolapse and normal subjects..
80.
1989
-
Recovery-phase patterns of ST segment depression in the heart rate domain. Identification of coronary artery disease by the rate-recovery loop..
80.
1989
-
Heart rate adjustment of ST segment depression for improved detection of coronary artery disease..
79.
1989
-
Platelet thrombus formation on collagen type I. A model of deep vessel injury. Influence of blood rheology, von Willebrand factor, and blood coagulation..
78.
1988
-
Reduced lymphocyte stimulatory guanine nucleotide regulatory protein and beta-adrenergic receptors in congestive heart failure and reversal with angiotensin converting enzyme inhibitor therapy..
78.
1988
-
Quantification of infarct size by 201Tl single-photon emission computed tomography during acute myocardial infarction in humans. Comparison with enzymatic estimates..
78.
1988
-
Increased preferential absorption in human atherosclerotic plaque with oral beta carotene. Implications for laser endarterectomy..
78.
1988
-
Mitral valve prolapse and severe mitral regurgitation..
78.
1988
-
Morning increase in platelet aggregability. Association with assumption of the upright posture..
78.
1988
-
Wideband external pulse recording during cuff deflation: a new technique for evaluation of the arterial pressure pulse and measurement of blood pressure..
77.
1988
-
The relationship between left ventricular systolic function and congestive heart failure diagnosed by clinical criteria..
77.
1988
-
Surgical ablation of ventricular tachycardia with sequential map-guided subendocardial resection: electrophysiologic assessment and long-term follow-up..
77.
1988
-
Myocardial perfusion abnormalities in patients with hypertrophic cardiomyopathy: assessment with thallium-201 emission computed tomography..
76.
1987
-
Predictors of efficacy of amiodarone and characteristics of recurrence of arrhythmia in patients with sustained ventricular tachycardia and coronary artery disease..
76.
1987
-
The hemodynamic effects of sotalol and quinidine: analysis by use of rest and exercise gated radionuclide angiography..
76.
1987
-
Differential electrophysiologic properties of decremental retrograde pathways in long RP' tachycardia..
76.
1987
-
Improved sex-specific criteria of left ventricular hypertrophy for clinical and computer interpretation of electrocardiograms: validation with autopsy findings..
75.
1987
-
Association of levels of lipoprotein Lp(a), plasma lipids, and other lipoproteins with coronary artery disease documented by angiography..
74.
1986
-
Adenosine-sensitive ventricular tachycardia: evidence suggesting cyclic AMP-mediated triggered activity..
74.
1986
-
Surgical ablation of ventricular tachycardia: improved results with a map-directed regional approach..
73.
1986
-
Mitral regurgitation: relationship of noninvasive descriptors of right and left ventricular performance to clinical and hemodynamic findings and to prognosis in medically and surgically treated patients..
73.
1986
-
Efficacy and safety of moricizine in patients with ventricular tachycardia: results of a placebo-controlled prospective long-term clinical trial..
73.
1986
-
Indium-111 platelet scintigraphy for the diagnosis of acute venous thrombosis..
73.
1986
-
Accurate noninvasive quantification of stenotic aortic valve area by Doppler echocardiography..
73.
1986
-
Maintenance of exercise stroke volume during ventricular versus atrial synchronous pacing: role of contractility..
72.
1985
-
Exercise thallium-201 scintigraphy in dogs: effects of long-term coronary occlusion and collateral development on early and late scintigraphic images..
72.
1985
-
Some reflections on arteriosclerosis: past, present, and future..
72.
1985
-
Autoimmune myocarditis induced by Trypanosoma cruzi..
71.
1985
-
Determination of parameters of left ventricular diastolic filling with pulsed Doppler echocardiography: comparison with cineangiography..
71.
1985
-
Directions of atherosclerosis research in the 1980s and 1990s..
70.
1984
-
Pulsed Doppler echocardiographic determination of stroke volume and cardiac output: clinical validation of two new methods using the apical window..
70.
1984
-
Myocardial injury and induction of arrhythmia by direct current shock delivered via endocardial catheters in dogs..
69.
1984
-
Recommendations for treatment of hyperlipidemia in adults. A joint statement of the Nutrition Committee and the Council on Arteriocslerosis..
69.
1984
-
Comparative effect of disopyramide and ethmozine in suppressing complex ventricular arrhythmias by use of a double-blind, placebo-controlled, longitudinal crossover design..
69.
1984
-
Left ventricular hypertrophy in patients with hypertension: importance of blood pressure response to regularly recurring stress..
68.
1983
-
Detection of coronary artery disease with exercise two-dimensional echocardiography. Description of a clinically applicable method and comparison with radionuclide ventriculography..
67.
1983
-
Geometric determinants of electrocardiographic left ventricular hypertrophy..
67.
1983
-
Quantification of left ventricular volumes by two-dimensional echocardiography: a simplified and accurate approach..
67.
1983
-
The potential impact of nuclear magnetic resonance imaging on cardiovascular diagnosis..
67.
1983
-
Occupational screenings: recruitment from private industry..
66.
1982
-
The influence of residual disease after coronary bypass on the 5-year survival rate of 1274 men with coronary artery disease..
66.
1982
-
Clinical results of coronary bypass in 500 patients at least 10 years after operation..
66.
1982
-
Left ventricular volume and function during relief of cardiac tamponade in man..
66.
1982
-
Survival after coronary artery bypass surgery in specific patient groups..
65.
1982
-
Gamma camera quantitation of thallium-210 redistribution at rest in a dog model..
65.
1982
-
A new, simplified and accurate method for determining ejection fraction with two-dimensional echocardiography..
64.
1981
-
Left ventricular diastolic performance at rest and during exercise in patients with coronary artery disease. Assessment with first-pass radionuclide angiography..
63.
1981
-
Left ventricular hypertrophy: relationship of anatomic, echocardiographic and electrocardiographic findings..
63.
1981
-
A new approach for evaluating risk factors in coronary artery disease: a study of lipid concentrations and severity of disease in 1847 males..
62.
1980
-
Pulsed doppler echocardiographic measurement of beat-to-beat changes in stroke volume in dogs..
62.
1980
-
Bypass graft surgery in severe left ventricular dysfunction..
62.
1980
-
Exercise tolerance in late survivors of balloon pumping and surgery for cardiogenic shock..
62.
1980
-
Echo-phonocardiographic determination of left atrial and left ventricular filling pressures with and without mitral stenosis..
61.
1980
-
Relationship between plasma lipid concentrations and coronary artery disease in 496 patients..
56.
1977
-
Echocardiographic determination of left ventricular mass in man. Anatomic validation of the method..
55.
1977
-
Operative management of tricuspid regurgitation..
54.
1976
-
Left atrial enlargement. Echocardiographic assessment of electrocardiographic criteria..
54.
1976
-
Influence of acute changes in preload, afterload, contractile state and heart rate on ejection and isovolumic indices of myocardial contractility in man..
53.
1976
-
Cerebrospinal fluid acidosis complicating therapy of experimental cardiopulmonary arrest..
52.
1975
-
Long-term survival following coronary bypass surgery in patients with significant impairment of left ventricular function..
52.
1975
-
Echocardiographic determination of left ventricular stress-velocity relations..
51.
1975
-
Dynamic determinants of letf ventricular diastolic pressure-volume relations in man..
51.
1975
-
The anatomic substrate of complete left bundle branch block..
50.
1974
-
Changes in the underlying coronary circulation secondary to bypass grafting..
50.
1974
-
Factors influencing long-term survival after isolated aortic valve replacement..
50.
1974
-
Echocardiographic assessment of left ventricular function with special reference to normalized velocities..
50.
1974
-
Reduction in the rate of diastolic descent of the mitral valve echogram in patients with altered left ventricular diastolic pressure-volume relations..
49.
1974
-
Left main coronary artery stenosis; results of coronary bypass surgery..
49.
1974
-
Evaluation of anticoagulant therapy in cloth-covered prosthetic valves..
48.
1973
-
Effects of surgery on angina (pre- and postinfarction) and myocardical function (failure)..
46.
1972
-
Determinants of angiographic patency of aortocoronary vein bypass grafts..
45.
1972
-
Heart failure complicating acute myocardial infarction..
45.
1972
-
Response of Cardiac Surgery Units to COVID-19: An Internationally-Based Quantitative Survey..
142.
2020
-
Characterization of Endovascular Abdominal Aortic Aneurysm Repair Surveillance in the Vascular Quality Initiative..
141.
2020
-
Prognostic Implications of Diffuse Interstitial Fibrosis in Asymptomatic Primary Mitral Regurgitation..
140.
2019
-
Hospital Volume Association With Abdominal Aortic Aneurysm Repair Mortality: Analysis of the International Consortium of Vascular Registries..
140.
2019
-
Sex Differences in the Etiology of Surgical Mitral Valve Disease..
138.
2018
-
Response to Letter Regarding Article, "Southern Dietary Pattern is Associated With Hazard of Acute Coronary Heart Disease in the Reasons for Geographic and Racial Differences in Stroke (REGARDS) Study"..
133.
2016
-
Response to Letter Regarding Article, "Circulating MicroRNA-30d Is Associated With Response to Cardiac Resynchronization Therapy in Heart Failure and Regulates Cardiomyocyte Apoptosis: A Translational Pilot Study"..
133.
2016
-
Response to Letter Regarding Article "Transdifferentiation of Human Fibroblasts to Endothelial Cells: Role of Innate Immunity"..
132.
2015
-
Letter from Cohen and Alderman regarding article, "lower levels of sodium intake and reduced cardiovascular risk"..
130.
2014
-
Response to letter regarding article, "growth properties of cardiac stem cells are a novel biomarker of patients' outcome after coronary bypass surgery"..
130.
2014
-
Comment on the reports of over-estimation of ASCVD risk using the 2013 AHA/ACC risk equation..
129.
2013
-
Letter by Benedetto et al regarding article, "Importance of refractory pain and hypertension in acute type B aortic dissection: insights from the International Registry of Acute Aortic Dissection (IRAD)"..
123.
2011
-
Letter by Wells and Eisenberg regarding article, "Statins for the primary prevention of cardiovascular events in women with elevated high-sensitivity C-reactive protein or dyslipidemia: results from the Justification for the Use of Statins in Prevention: an Intervention Trial Evaluating Rosuvastatin (JUPITER) and meta-analysis of women from primary prevention trials"..
122.
2010
-
Letter by O'Rourke et al regarding article, "Arterial stiffness and cardiovascular events: the Framingham Heart Study"..
122.
2010
-
Letter by Nagueh et al regarding article, "Tissue Doppler imaging in the estimation of intracardiac filling pressure in decompensated patients with advanced systolic heart failure"..
120.
2009
-
Letter by Stuehlinger et al regarding article, "Metabolic profiling of arginine and nitric oxide pathways predicts hemodynamic abnormalities and mortality in patients with cardiogenic shock after acute myocardial infarction"..
118.
2008
-
Letter by Kielstein et al regarding article, "Renal function as a predictor of outcome in a broad spectrum of patients with heart failure"..
114.
2006
-
The cardiology patient page. Statins: powerful drugs for lowering cholesterol: advice for patients..
105.
2002
-
AHA/ACC Scientific Statement: AHA/ACC guidelines for preventing heart attack and death in patients with atherosclerotic cardiovascular disease: 2001 update: A statement for healthcare professionals from the American Heart Association and the American College of Cardiology..
104.
2001
-
Transcatheter alcohol septal ablation for hypertrophic obstructive cardiomyopathy..
100.
1999
-
The academic life of a noninvasive test..
82.
1990
-
Taking a load off: nuclear remodeling after mechanically supporting the failing human heart.
2010
-
Is the electrocardiogram still useful for detection of left ventricular hypertrophy?
1990
-
Prevalence of Diabetes and Cardiovascular Risk in the Middle East and Africa: Primary Results of the PACT-MEA Study.
2023
-
Response by Leor et al to Letter Regarding Article, "Extracellular Vesicles From Epicardial Fat Facilitate Atrial Fibrillation".
2021
-
Association Between Cervical Artery Dissection and Aortic Dissection.
2021
-
A Return to Normal Is Not Good Enough.
2021
-
Temporal Trends in the Proportion of Women Physician Speakers at Major Cardiovascular Conferences.
2021
-
Protecting Medical Trainees on the COVID-19 Frontlines Saves Us All.
2020
-
The Role of the American Heart Association in the Global COVID-19 Pandemic.
2020
-
Translating Science Into Policy: An Important Collaboration Among Researchers, Clinicians, and Advocacy at the American Heart Association.
2019
-
Reduction of Cardiovascular Mortality and Ischemic Events in Acute Medically Ill Patients.
2019
-
Association Between Female Corresponding Authors and Female Co-Authors in Top Contemporary Cardiovascular Medicine Journals.
2019
-
Extended-Duration Betrixaban Reduces the Risk of Rehospitalization Associated With Venous Thromboembolism Among Acutely Ill Hospitalized Medical Patients: Findings From the APEX Trial (Acute Medically Ill Venous Thromboembolism Prevention With Extended Duration Betrixaban Trial).
2018
-
Response by Redfors and Généreux to Letter Regarding Article, "Stress Testing in Asymptomatic Aortic Stenosis".
2017
-
Response by Kamel to Letter Regarding Article, "Pregnancy and the Risk of Aortic Dissection or Rupture: A Cohort-Crossover Analysis".
2017
-
Response to Letters Regarding Article, "Frequency and Predictors of Internal Mammary Artery Graft Failure and Subsequent Clinical Outcomes: Insights From the Project of Ex-Vivo Vein Graft Engineering via Transfection (PREVENT) IV Trial".
2016
-
Response to letter regarding article, "Stent thrombosis with ticagrelor versus clopidogrel in patients with acute coronary syndromes: an analysis from the prospective, randomized PLATO trial".
2014
-
Response to letters regarding article, “Conversion of cardiovascular conference abstracts to publications”.
2013
-
Response to letter regarding article, “sustained ventricular tachycardia and ventricular fibrillation complicating non–ST-segment elevation acute coronary syndromes”.
2013
-
Letter regarding article by Patti et al, "Randomized trial of high loading dose of clopidogrel for reduction of periprocedural myocardial infarction in patients undergoing coronary intervention: results from the ARMYDA-2 (Antiplatelet therapy for Reduction of MYocardial Damage during Angioplasty) study".
2005
-
Exercise-induced ischemia and carotid atherosclerosis.
1999
-
Rapport?
1999
-
Does the early hazard phenomenon exist? Do the GUSTO findings prove or disprove?
1997
-
Echocardiographic estimation of mean right atrial pressure: how to obtain an estimate in all patients?
1997
-
Dobutamine echocardiography.
1995
-
Earlier diagnosis and treatment of acute myocardial infarction necessitates the need for a "new diagnostic mind-set".
1994
-
Left ventricular mass in hypertension.
1990
-
Determinants of ECG LVH.
1980
-
2020 American Heart Association and American College of Cardiology Consensus Conference on Professionalism and Ethics: A Consensus Conference Report.
2021
-
AHA/ACC/HHS strategies to enhance application of clinical practice guidelines in patients with cardiovascular disease and comorbid conditions: from the American Heart Association, American College of Cardiology, and US Department of Health and Human Services.
2014
-
New mechanistic and therapeutic targets for pediatric heart failure: report from a National Heart, Lung, and Blood Institute working group.
2014
-
ACCF/AHA clinical practice guideline methodology summit report: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines.
2012
-
Part 11: Neonatal resuscitation: 2010 International Consensus on Cardiopulmonary Resuscitation and Emergency Cardiovascular Care Science With Treatment Recommendations.
2010
-
Part 1: Executive summary: 2010 International Consensus on Cardiopulmonary Resuscitation and Emergency Cardiovascular Care Science With Treatment Recommendations.
2010
-
Part 3: Evidence evaluation process: 2010 International Consensus on Cardiopulmonary Resuscitation and Emergency Cardiovascular Care Science With Treatment Recommendations.
2010
-
Part 4: Conflict of interest management before, during, and after the 2010 International Consensus Conference on Cardiopulmonary Resuscitation and Emergency Cardiovascular Care Science With Treatment Recommendations.
2010
-
ACCF/AHA 2009 expert consensus document on pulmonary hypertension: a report of the American College of Cardiology Foundation Task Force on Expert Consensus Documents and the American Heart Association: developed in collaboration with the American College of Chest Physicians, American Thoracic Society, Inc., and the Pulmonary Hypertension Association.
2009
-
ACCF/ACG/AHA 2008 expert consensus document on reducing the gastrointestinal risks of antiplatelet therapy and NSAID use: a report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents.
2008
-
Report of the National Heart, Lung, and Blood Institute and National Marfan Foundation Working Group on research in Marfan syndrome and related disorders.
2008
-
Prevention strategies for cardiovascular disease in HIV-infected patients.
2008
-
Scientific knowledge gaps and clinical research priorities for cardiopulmonary resuscitation and emergency cardiovascular care identified during the 2005 International Consensus Conference on ECC [corrected] and CPR science with treatment recommendations: a consensus statement from the International Liaison Committee on Resuscitation (American Heart Association, Australian Resuscitation Council, European Resuscitation Council, Heart and Stroke Foundation of Canada, InterAmerican Heart Foundation, Resuscitation Council of Southern Africa, and the New Zealand Resuscitation Council); the American Heart Association Emergency Cardiovascular Care Committee; the Stroke Council; and the Cardiovascular Nursing Council.".
2007
-
ACCF/AHA/CDC conference report on emerging infectious diseases and biological terrorism threats: the clinical and public health implications for the prevention and control of cardiovascular diseases.
2007
-
ACCF/AHA 2007 clinical expert consensus document on coronary artery calcium scoring by computed tomography in global cardiovascular risk assessment and in evaluation of patients with chest pain: a report of the American College of Cardiology Foundation Clinical Expert Consensus Task Force (ACCF/AHA Writing Committee to Update the 2000 Expert Consensus Document on Electron Beam Computed Tomography).
2007
-
Percutaneous recanalization of chronically occluded coronary arteries: a consensus document: part I.
2005
-
Discovering the full spectrum of cardiovascular disease: Minority Health Summit 2003: report of the Obesity, Metabolic Syndrome, and Hypertension Writing Group.
2005
-
Prevention Conference VII: Obesity, a worldwide epidemic related to heart disease and stroke: Group IV: prevention/treatment.
2004
-
ACCF/AHA consensus conference report on professionalism and ethics.
2004
-
Low high-density lipoprotein cholesterol as a risk factor in coronary heart disease: a working group report.
2001
-
Lowering LDL cholesterol: questions from recent meta-analyses and subset analyses of clinical trial DataIssues from the Interdisciplinary Council on Reducing the Risk for Coronary Heart Disease, ninth Council meeting.
1999
-
Trials and Tribulations of Randomized Clinical Trials..
146.
2022
-
Endotheliopathy of Obesity..
142.
2020
-
Intracerebral Hemorrhage, Racial Disparities, and Access to Care..
134.
2016
-
Postpartum Hypertension: "It Ain't Over 'til It's Over"..
132.
2015
-
Cardiac magnetic resonance imaging and sudden death risk in patients with hypertrophic cardiomyopathy..
130.
2014
-
Grabbing the horns of a dilemma: the duration of dual antiplatelet therapy after stent implantation..
125.
2012
-
Low-gradient "severe" aortic stenosis with normal systolic function: time to refine the guidelines?.
123.
2011
-
Improving lipid goal attainment: is it enough?.
120.
2009
-
Inflammation and cardiovascular disease: role of the interleukin-1 receptor antagonist..
117.
2008
-
Podagra, uric acid, and cardiovascular disease..
116.
2007
-
Women, acute ischemic heart disease, and antithrombotic therapy: challenges and opportunities..
115.
2007
-
Statin therapy and the elderly: SAGE advice?.
115.
2007
-
Electrocardiography in women: taking the initiative..
113.
2006
-
Genetic and acquired determinants of individual variability of response to antiplatelet drugs..
108.
2003
-
Reducing the risk for stroke in patients with myocardial infarction: a Myocardial Ischemia Reduction with Aggressive Cholesterol Lowering (MIRACL) substudy..
106.
2002
-
Nitric oxide and angiogenesis..
105.
2002
-
Eligibility for lipid-lowering drug therapy in primary prevention: how do the Adult Treatment Panel II and Adult Treatment Panel III Guidelines compare?.
105.
2002
-
Go with the flow..
103.
2001
-
Angiogenesis and atherosclerosis. The mandate broadens..
100.
1999
-
Dobutamine MRI: A serious contender in pharmacological stress imaging?.
99.
1999
-
Triglyceride: the forgotten risk factor..
97.
1998
-
Lipoprotein(a): molecular mischief in the microvasculature..
96.
1997
-
Derangements of the nitric oxide synthase pathway, L-arginine, and cardiovascular diseases..
96.
1997
-
Do antihypertensive drugs differ in their ability to regress left ventricular hypertrophy?.
95.
1997
-
Risk stratification after myocardial infarction. Clinical science versus practice behavior..
95.
1997
-
Arginine: a new therapy for atherosclerosis?.
95.
1997
-
Intracoronary stents. A breakthrough technology or just another small step?.
89.
1994
-
Cytoprotective effects of nitric oxide..
88.
1993
-
Serum cholesterol. Doing the right thing..
88.
1993
-
'Silent ischemia,' ventricular arrhythmias, and complications of hypertension..
85.
1992
-
Diet and coronary heart disease: the statistical analysis of risk..
63.
1981
-
Considerations for Reduction of Risk of Perioperative Stroke in Adult Patients Undergoing Cardiac and Thoracic Aortic Operations: A Scientific Statement From the American Heart Association.
2020
-
Arterial Grafts for Coronary Bypass: A Critical Review After the Publication of ART and RADIAL.
2019
-
Continuing Conundrum of Multiple Arterial Conduits for Coronary Artery Bypass Grafting.
2018
-
Pacing as a Treatment for Reflex-Mediated (Vasovagal, Situational, or Carotid Sinus Hypersensitivity) Syncope: A Systematic Review for the 2017 ACC/AHA/HRS Guideline for the Evaluation and Management of Patients With Syncope: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society.
2017
-
The Evolution of Coronary Bypass Surgery Will Determine Its Relevance as the Standard of Care for the Treatment for Multivessel Coronary Artery Disease.
2016
-
Degenerative Mitral Stenosis: Unmet Need for Percutaneous Interventions.
2016
-
Anderson-Fabry disease and other lysosomal storage disorders.
2014
-
Cancer therapy-induced cardiac toxicity in early breast cancer: addressing the unresolved issues.
2012
-
Part 15: neonatal resuscitation: 2010 American Heart Association Guidelines for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care.
2010
-
Part 1: executive summary: 2010 American Heart Association Guidelines for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care.
2010
-
Stem cell therapy for vascular regeneration: adult, embryonic, and induced pluripotent stem cells.
2010
-
Current perspectives on cardiac function in patients with diastolic heart failure.
2009
-
Congenital and acquired pulmonary vein stenosis.
2007
-
Exercise electrocardiogram testing: beyond the ST segment.
2006
-
Molecular basis of arrhythmias.
2005
-
Exercise testing in asymptomatic adults: a statement for professionals from the American Heart Association Council on Clinical Cardiology, Subcommittee on Exercise, Cardiac Rehabilitation, and Prevention.
2005
-
Update on statins: 2003.
2004
-
HDL cholesterol and protective factors in atherosclerosis.
2004
-
Inflammation in atherosclerosis and implications for therapy.
2004
-
Asymmetrical dimethylarginine: the Uber marker?
2004
-
Risk reduction.
2000
-
Platelet glycoprotein IIb/IIIa antagonists. What are the relevant issues concerning their pharmacology and clinical use?
1999
-
Use of sildenafil (Viagra) in patients with cardiovascular disease. Technology and Practice Executive Committee.
1999
-
Cholesterol management in theory and practice.
1997
-
Clinical trials for claudication. Assessment of exercise performance, functional status, and clinical end points. Vascular Clinical Trialists.
1995
-
Earlier diagnosis and treatment of acute myocardial infarction necessitates the need for a 'new diagnostic mind-set'.
1994
-
Vascular biology and medicine in the 1990s: scope, concepts, potentials, and perspectives.
1993
-
Cardiac electrophysiology of adenosine. Basic and clinical concepts.
1991
-
Mechanisms of abnormal transmembrane signaling of the beta-adrenergic receptor in congestive heart failure.
1990
-
The cholesterol facts. A summary of the evidence relating dietary fats, serum cholesterol, and coronary heart disease. A joint statement by the American Heart Association and the National Heart, Lung, and Blood Institute. The Task Force on Cholesterol Issues, American Heart Association.
1990
-
Implementation Science to Achieve Equity in Heart Failure Care: A Scientific Statement From the American Heart Association.
2024
-
2023 International Consensus on Cardiopulmonary Resuscitation and Emergency Cardiovascular Care Science With Treatment Recommendations: Summary From the Basic Life Support; Advanced Life Support; Pediatric Life Support; Neonatal Life Support; Education, Implementation, and Teams; and First Aid Task Forces.
2023
-
Food Is Medicine: A Presidential Advisory From the American Heart Association.
2023
-
Considerations on the Management of Acute Postoperative Ischemia After Cardiac Surgery: A Scientific Statement From the American Heart Association.
2023
-
Sarcopenia and Cardiovascular Diseases.
2023
-
Evaluation and Management of Pulmonary Hypertension in Noncardiac Surgery: A Scientific Statement From the American Heart Association.
2023
-
Surgical Management and Mechanical Circulatory Support in High-Risk Pulmonary Embolisms: Historical Context, Current Status, and Future Directions: A Scientific Statement From the American Heart Association.
2023
-
Nonprofit Advocacy at the American Heart Association: Creating a Visionary Way Forward at Our 40th Anniversary: An American Heart Association Policy Statement.
2021
-
Transcatheter Aortic Valve Replacement in Bicuspid Aortic Valve Stenosis.
2021
-
Invasive Management of Acute Myocardial Infarction Complicated by Cardiogenic Shock: A Scientific Statement From the American Heart Association.
2021
-
Taking a Stand Against Air Pollution-The Impact on Cardiovascular Disease: A Joint Opinion From the World Heart Federation, American College of Cardiology, American Heart Association, and the European Society of Cardiology.
2021
-
Research Priorities in Atrial Fibrillation Screening: A Report From a National Heart, Lung, and Blood Institute Virtual Workshop.
2021
-
Stroke Prevention in Atrial Fibrillation: Looking Forward.
2020
-
Considerations for Drug Interactions on QTc in Exploratory COVID-19 Treatment.
2020
-
Searching for Atrial Fibrillation Poststroke: A White Paper of the AF-SCREEN International Collaboration.
2019
-
2019 International Consensus on Cardiopulmonary Resuscitation and Emergency Cardiovascular Care Science With Treatment Recommendations: Summary From the Basic Life Support; Advanced Life Support; Pediatric Life Support; Neonatal Life Support; Education, Implementation, and Teams; and First Aid Task Forces.
2019
-
Revisiting the Role of Aspirin for the Primary Prevention of Cardiovascular Disease.
2019
-
Heart Centers for Women: Historical Perspective on Formation and Future Strategies to Reduce Cardiovascular Disease.
2018
-
Standardized Definition of Structural Valve Degeneration for Surgical and Transcatheter Bioprosthetic Aortic Valves.
2018
-
Handheld Echocardiography: Current State and Future Perspectives.
2017
-
Stress Testing in Asymptomatic Aortic Stenosis.
2017
-
Medical Treatment of Aortic Stenosis.
2016
-
Coronary Artery Bypass Surgery Is Not Underutilized!
2016
-
Trends in Enrollment, Clinical Characteristics, Treatment, and Outcomes According to Age in Non-ST-Segment-Elevation Acute Coronary Syndromes Clinical Trials.
2016
-
Moving from political declaration to action on reducing the global burden of cardiovascular diseases: a statement from the global cardiovascular disease taskforce.
2013
-
Our time: a call to save preventable death from cardiovascular disease (heart disease and stroke).
2012
-
Imaging for ventricular function and myocardial recovery on nonpulsatile ventricular assist devices.
2012
-
Impact of genetic insights into mendelian disease on cardiovascular clinical practice.
2011
-
Optimizing trial design: sequential, adaptive, and enrichment strategies.
2009
-
Pulmonary diseases and the heart.
2007
-
Percutaneous recanalization of chronically occluded coronary arteries: a consensus document: part II.
2005
-
Sustained ventricular arrhythmias among patients with acute coronary syndromes with no ST-segment elevation: incidence, predictors, and outcomes.
2002
-
Role of preclinical cardiovascular disease in the evolution from risk factor exposure to development of morbid events.
1993
-
Mitral valve prolapse.
1976
Identity
ISO Abbreviation
Linking ISSN
International Standard Serial Number (ISSN)
Electronic International Standard Serial Number (EISSN)